{"id":13377,"date":"2024-08-23T00:35:51","date_gmt":"2024-08-22T22:35:51","guid":{"rendered":"https:\/\/valintermed.com\/?p=13377"},"modified":"2024-08-23T00:35:51","modified_gmt":"2024-08-22T22:35:51","slug":"sindrom-van-maldergema","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/maldergema-syndrome-2\/","title":{"rendered":"Van Malderghem syndrome"},"content":{"rendered":"<div class=\"fpm_start\"><\/div>\n<p>Van Malderghem syndrome (VAN Malderghem) is a rare genetic disorder characterized by specific abnormalities in the patient&#039;s body, including mental retardation, physical developmental disorders, and various hormonal abnormalities. This disorder is classified as a sex-linked disorder and has clearly defined genetic causes, namely mutations in the XH gene and other genes associated with the development of sexual characteristics. Problems with the endocrine system can affect both men and women, but patients usually have symptoms that are more severe in men. The disease has its own characteristics due to its hereditary nature and specific clinical picture.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_85 counter-flat ez-toc-counter ez-toc-light-blue ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Content<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 eztoc-toggle-hide-by-default' ><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/maldergema-syndrome-2\/#%D0%98%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%8F_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D0%B8_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D0%B5%D1%81%D0%BD%D1%8B%D0%B5_%D0%B8%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D1%84%D0%B0%D0%BA%D1%82%D1%8B\" >History of the disease and interesting historical facts<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/maldergema-syndrome-2\/#%D0%AD%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F\" >Epidemiology<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/maldergema-syndrome-2\/#%D0%93%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%80%D0%B0%D1%81%D0%BF%D0%BE%D0%BB%D0%BE%D0%B6%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C_%D0%BA_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%BC%D1%83_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8E\" >Genetic predisposition to this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/maldergema-syndrome-2\/#%D0%A4%D0%B0%D0%BA%D1%82%D0%BE%D1%80%D1%8B_%D1%80%D0%B8%D1%81%D0%BA%D0%B0_%D0%B2%D0%BE%D0%B7%D0%BD%D0%B8%D0%BA%D0%BD%D0%BE%D0%B2%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Risk factors for the development of this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/maldergema-syndrome-2\/#%D0%94%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Diagnosis of this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/maldergema-syndrome-2\/#%D0%9B%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5\" >Treatment<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/maldergema-syndrome-2\/#%D0%A1%D0%BF%D0%B8%D1%81%D0%BE%D0%BA_%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2_%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D1%8B%D1%85_%D0%B4%D0%BB%D1%8F_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >List of medications used to treat this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/maldergema-syndrome-2\/#%D0%9C%D0%BE%D0%BD%D0%B8%D1%82%D0%BE%D1%80%D0%B8%D0%BD%D0%B3_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Disease monitoring<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/maldergema-syndrome-2\/#%D0%92%D0%BE%D0%B7%D1%80%D0%B0%D1%81%D1%82%D0%BD%D1%8B%D0%B5_%D0%BE%D1%81%D0%BE%D0%B1%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D0%B8_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Age-related features of the disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/maldergema-syndrome-2\/#%D0%92%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%8B_%D0%B8_%D0%BE%D1%82%D0%B2%D0%B5%D1%82%D1%8B\" >Questions and Answers<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"%D0%98%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%8F_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D0%B8_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D0%B5%D1%81%D0%BD%D1%8B%D0%B5_%D0%B8%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D1%84%D0%B0%D0%BA%D1%82%D1%8B\"><\/span>History of the disease and interesting historical facts<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Van Malderghem syndrome was first described in 1980 by geneticists who noticed a few cases that presented in a similar manner. Research showed that the syndrome was rare and mostly occurred in individuals with certain mutations in genes associated with sexual differentiation. Subsequently, the size of these patient groups began to grow due to the increased availability of genetic tests and a more thorough study of the syndrome in the medical community. Importantly, in some cases the syndrome could only be adequately assessed after conducting multi-level genetic testing, which emphasizes the importance of genetic diagnosis in understanding the disease. Additionally, the creation of communities of patients with this syndrome has documented various aspects of quality of life and treatment, raising the importance of the problem to an international level.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%AD%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F\"><\/span>Epidemiology<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Statistics on the occurrence of Van Malderghem syndrome are currently limited, as the disease has been described relatively recently and is rare. According to review studies, the ratio of cases among men to women is approximately 3:1. Since the disease is genetic, its prevalence may vary depending on the geographic region and ethnicity. The incidence of the syndrome is estimated to be 1 in 100,000-200,000 live births. However, due to under-research and lack of awareness among the population and physicians, many cases may remain undiagnosed, which requires further investigation. The presence of familial cases indicates possible hereditary mechanisms, and in this regard, cases where the syndrome was not diagnosed early in life should also be considered.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%93%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%80%D0%B0%D1%81%D0%BF%D0%BE%D0%BB%D0%BE%D0%B6%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C_%D0%BA_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%BC%D1%83_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8E\"><\/span>Genetic predisposition to this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The genetic basis of Van Malderghem syndrome is associated with mutations in a number of key genes responsible for the development of the reproductive system. The most common mutation is in the gene encoding the androgen receptor (AR). Mutations may also be observed in other important genes, such as SOX9 and AMH, which direct the development of male sexual characteristics. The syndrome is transmitted recessively, meaning that both parents must have an allele of the gene associated with the pathology for the disease to manifest. Research shows that in some cases new mutations may also be observed that arise independently of the hereditary factor, which also opens up new horizons for understanding the mechanism of the disease and the prospects for gene therapy.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A4%D0%B0%D0%BA%D1%82%D0%BE%D1%80%D1%8B_%D1%80%D0%B8%D1%81%D0%BA%D0%B0_%D0%B2%D0%BE%D0%B7%D0%BD%D0%B8%D0%BA%D0%BD%D0%BE%D0%B2%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Risk factors for the development of this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>There are several risk factors that contribute to the development of Van Malderghem syndrome, including both physical and chemical factors. The main factors include:<\/p>\n<ul>\n<li>Genetic predisposition: the presence of a hereditary load in the family.<\/li>\n<li>Exogenous factors: potential exposure of a pregnant woman to carcinogenic chemicals or radiation.<\/li>\n<li>Maternal age: increased risk in women over 35 years of age, due to changes in genetic material.<\/li>\n<\/ul>\n<p>All of these factors highlight the need for a detailed analysis of the patient&#039;s family history and lifestyle at the pregnancy planning stage and during the course of previous observation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%94%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Diagnosis of this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Correct diagnosis of Van Malderghem syndrome requires a multidisciplinary approach and involves several steps. The main symptoms can vary, but usually include:<\/p>\n<ul>\n<li>Mental retardation or delayed psychomotor development.<\/li>\n<li>Abnormalities of the genital organs or development of secondary sexual characteristics.<\/li>\n<li>A number of endocrine disorders.<\/li>\n<\/ul>\n<p>Laboratory tests may include:<\/p>\n<ul>\n<li>Genetic testing (search for mutations in genes associated with sexual differentiation).<\/li>\n<li>Hormonal tests to assess the function of the endocrine system.<\/li>\n<li>Comprehensive examination using molecular genetic methods.<\/li>\n<\/ul>\n<p>Radiological examinations may be aimed at identifying anatomical abnormalities of the pelvic organs. In addition, an important component is the differential diagnosis, which is necessary to exclude other genetic disorders, such as Klinefelter syndrome or various variations of intersex conditions.<\/p><script data-noptimize=\"\" data-wpfc-render=\"false\">\nfpm_start( \"true\" );\n<\/script>\n\n<h2><span class=\"ez-toc-section\" id=\"%D0%9B%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5\"><\/span>Treatment<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Treatment of Van Malderghem syndrome requires a comprehensive approach and adaptation to the individual characteristics of each patient. It may include:<\/p>\n<ul>\n<li>General treatment: rehabilitation programs to improve the patient&#039;s quality of life and functional capabilities.<\/li>\n<li>Pharmacological treatment: prescribing drugs to correct hormonal levels and support overall health.<\/li>\n<li>Surgical treatment: possible in cases of significant anatomical anomalies requiring correction.<\/li>\n<li>Other treatments include psychological support, speech therapy, and special educational programs.<\/li>\n<\/ul>\n<p>It is important to take into account that each strategy requires an individual approach and regular monitoring of the patient&#039;s condition.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A1%D0%BF%D0%B8%D1%81%D0%BE%D0%BA_%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2_%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D1%8B%D1%85_%D0%B4%D0%BB%D1%8F_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>List of medications used to treat this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the medications used, the following can be distinguished:<\/p>\n<ul>\n<li>Hormones such as testosterone or estrogen, depending on sexual differentiation.<\/li>\n<li>Drugs for the correction of endocrine disorders, such as metformin for insulin resistance.<\/li>\n<li>Antidepressants and anxiolytics to manage psychological problems associated with the disease.<\/li>\n<\/ul>\n<p>Each of the above mentioned remedies should be prescribed individually, based on complete tests and medical history.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%9C%D0%BE%D0%BD%D0%B8%D1%82%D0%BE%D1%80%D0%B8%D0%BD%D0%B3_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Disease monitoring<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Monitoring of Van Malderghem syndrome consists of regular check-ups to assess the patient&#039;s condition, including:<\/p>\n<ul>\n<li>Regular medical check-ups with genetic testing to monitor for possible changes.<\/li>\n<li>Evaluation of hormonal status in dynamics using endocrinological tests.<\/li>\n<li>Psychological support and correction of behavioral problems.<\/li>\n<\/ul>\n<p>The prognosis with early treatment may be favorable, but in the absence of proper medical care, serious complications are possible, such as endocrine system disorders and psychological disorders.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%92%D0%BE%D0%B7%D1%80%D0%B0%D1%81%D1%82%D0%BD%D1%8B%D0%B5_%D0%BE%D1%81%D0%BE%D0%B1%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D0%B8_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Age-related features of the disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Van Malderghem syndrome manifests itself differently depending on the age group:<\/p>\n<ul>\n<li>In newborns: symptoms may be subtle and manifest themselves in the absence of clearly defined sexual characteristics.<\/li>\n<li>In children: delays in mental and physical development and various anomalies in the structure of the genitals may be detected.<\/li>\n<li>In adolescents: changes associated with puberty and the development of secondary sexual characteristics are examined.<\/li>\n<li>In adults: need for supportive therapy and correction of hormonal levels.<\/li>\n<\/ul>\n<p>Treatment and monitoring approaches are also individualized based on the patient&#039;s age, ensuring optimal outcome in monitoring this rare disease.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%92%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%8B_%D0%B8_%D0%BE%D1%82%D0%B2%D0%B5%D1%82%D1%8B\"><\/span>Questions and Answers<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>What are the characteristic symptoms of Van Malderghem syndrome?<\/strong> Characteristic symptoms include mental retardation, disorders of sexual development, endocrine abnormalities, and delayed psychomotor development.<\/li>\n<li><strong>How is Van Malderghem syndrome diagnosed?<\/strong> Diagnosis is made through genetic testing, hormonal analysis and assessment of the clinical picture of the disease.<\/li>\n<li><strong>How is Van Malderghem syndrome treated?<\/strong> Treatment includes general rehabilitation, pharmacological therapy, surgical interventions, as well as psychological and speech therapy support.<\/li>\n<li><strong>Can Van Malderghem syndrome be prevented?<\/strong> Prevention includes genetic counseling, especially for families with a history of the disease, and avoidance of exposure to exogenous factors during pregnancy.<\/li>\n<li><strong>What is the prognosis for patients with Van Malderghem syndrome?<\/strong> The prognosis depends on timely diagnosis and implementation of therapeutic measures, however, in the absence of treatment, serious endocrine and psycho-emotional disorders may occur.<\/li>\n<\/ul>\n<div class=\"fpm_end\"><\/div>","protected":false},"excerpt":{"rendered":"<p>Van Malderghem syndrome (VAN Malderghem) is a rare genetic disorder characterized by specific abnormalities in the patient&#039;s body, including mental retardation,<\/p>","protected":false},"author":1,"featured_media":23930,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[298],"tags":[],"class_list":["post-13377","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medlibrary"],"_links":{"self":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/13377","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/comments?post=13377"}],"version-history":[{"count":1,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/13377\/revisions"}],"predecessor-version":[{"id":13540,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/13377\/revisions\/13540"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/media\/23930"}],"wp:attachment":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/media?parent=13377"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/categories?post=13377"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/tags?post=13377"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}